Shattuck Labs (STTK) Net Margin (2019 - 2025)
Shattuck Labs' (STTK) quarterly Net Margin came in at 1111.6% in Q3 2025, down 48698.0% year-on-year from N/an in Q3 2024, and down 77.96% on a QoQ basis from 624.62% in Q3 2024.
Shattuck Labs (STTK) Net Margin (2019 - 2025) Analysis & Trends
Shattuck Labs (STTK) has 7 years of Net Margin data on file, last reported at 1111.6% in Q3 2025.
- On a quarterly basis, Net Margin fell 48698.0% year-over-year to 1111.6% in Q3 2025; TTM through Mar 2026 was 15907.1%, a 1217403.0% decrease from a year earlier, with the FY2025 full-year figure at 15549.1%, down 1255985.0% from the prior year.
- Net Margin for Q3 2025 stood at 1111.6%, down from 624.62% in the prior quarter.
- Over the last five years, Net Margin for STTK reached as high as 74.8% in Q4 2021 and fell as low as 58290.0% in Q2 2022.
- Historically, Net Margin has averaged 10556.2% across 5 years, with a median of 2909.78% in 2024.
- Across the five-year window, Net Margin sank 5711978 bps in 2022 and soared 4676650 bps in 2023, its largest moves.
- Year by year, Net Margin stood at 74.8% in 2021, then plunged by 8839 bps to 6686.15% in 2022, then tumbled by 100 bps to 13352.52% in 2023, then surged by 95 bps to 624.62% in 2024, then sank by 78 bps to 1111.6% in 2025.
- Per Business Quant data, the three most recent Net Margin figures were 1111.6% in Q3 2025, 624.62% in Q3 2024, and 1507.89% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,111.60% |
| Sep 30, 2024 | -624.62% |
| Jun 30, 2024 | -1,507.89% |
| Mar 31, 2024 | -2,909.78% |
| Dec 31, 2023 | -13,352.52% |
| Sep 30, 2023 | -4,183.38% |
| Jun 30, 2023 | -11,523.50% |
| Mar 31, 2023 | -38,352.63% |
| Dec 31, 2022 | -6,686.15% |
| Sep 30, 2022 | -14,939.62% |
| Jun 30, 2022 | -58,290.00% |
| Dec 31, 2021 | -74.80% |
| Sep 30, 2021 | -1,927.84% |
| Jun 30, 2021 | -1,170.22% |
| Mar 31, 2021 | -1,688.41% |
| Dec 31, 2020 | -2,177.42% |
| Sep 30, 2020 | -831.75% |
| Jun 30, 2020 | -194.34% |
| Mar 31, 2020 | -218.78% |
| Dec 31, 2019 | -552.11% |